| Original language | English (US) |
|---|---|
| Pages (from-to) | 76-77 |
| Number of pages | 2 |
| Journal | Journal of clinical psychopharmacology |
| Volume | 41 |
| Issue number | 1 |
| DOIs | |
| State | Published - 2021 |
Funding
A.L.M. and J.G. are employees of Indivior, Inc. For a list of lifetime disclosures for M.F., please see http://mghcme.org/ faculty/faculty-detail/maurizio_fava. J.C. has served as a DSMB member for Eli Lilly and Sanofi-Aventis. J.W.N. has received grant support from the National Institutes of Health, Substance Abuse and Mental Health Services Administration; has served as a consultant to Indivior, Sunovion, Intra-Cellular Therapies, Otsuka, and Alkermes; has been involved in patent litigation on behalf of Sunovion; and serves on a Data Safety Monitoring Board for Amgen.
ASJC Scopus subject areas
- Psychiatry and Mental health
- Pharmacology (medical)